Hemlibra 105 MG/0.7 ML vial 0.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1ZW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,418
Award facts
- Contract value 100% obligated
- $25,418.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 8, 2026, for the supply of Hemlibra 105 mg/0.7 mL vials. This firm fixed-price delivery order, valued at $25,418.12, is scheduled for completion by January 30, 2026, and will be fulfilled from the awardee's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
Hemlibra is a specialized hemophilia treatment used in federal military and veteran healthcare programs. AmerisourceBergen's contract portfolio with DLA demonstrates the company's significant role as a critical pharmaceutical vendor, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent company, Cencora, Inc., maintains an even larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, underscoring the company's prominent position in supplying specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military treatment facilities and federal healthcare institutions globally.
Quick answers
Who was awarded contract SPE2DR26FM1ZW?
SPE2DR26FM1ZW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM1ZW worth?
The government has obligated $25,418 on SPE2DR26FM1ZW.
Is contract SPE2DR26FM1ZW an order under another contract?
Yes. SPE2DR26FM1ZW is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1ZW competed?
The extent of competition for SPE2DR26FM1ZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award